420 with CNW — Three Tips for New Medical Cannabis Patients

Research has found that medical marijuana possesses therapeutic benefits, and with more states across the country legalizing the use of medical marijuana in alleviating and managing symptoms of various indications, it is important to acquaint yourself with what this means for you, especially if you qualify to use medical cannabis.

Most, if not all the states that have legalized its medical use, stipulate that a prescription should be given by a qualified doctor, which helps ensure that the use of medical cannabis doesn’t affect the effectiveness of other medications that are being taken.

Here are a few things new users of medical cannabis should know or do to ensure they stay healthy and safe while using medical cannabis.

Know the conditions eligible for medical cannabis use

Most states have established lists of the conditions or ailments for which eligible people are allowed to use medical cannabis.

The most common conditions eligible for medical cannabis use include:

Multiple sclerosis
Glaucoma
Arthritis
Epilepsy
Post-traumatic stress disorder
Chronic pain
Cancer

If your disease isn’t included on the list, you probably won’t receive clearance or get a prescription from your doctor to take medical cannabis. It should be noted, however, that the ailments can differ from state to state, so be sure to check with local medical authorities for confirmation.

Conduct your own research

The market today is filled with different kinds of medical cannabis products, which are not made equally. If you are eligible for medical marijuana use, ensure that you do your own research on these products, centering on manufacturers and products that have a reputation for good quality and performance.

Apart from taking advice from your physician, you can also use the internet for your research. In addition to this, you can talk to other patients who use medical marijuana and ask for their advice on what types of brands and products to trust.

Find out the different types of products available

A prescription from your doctor may not specify the particular product to be used. In most cases, prescriptions only specify the CBD amount and potency that should be in every product you will be using.

While budtenders and curators at the dispensaries may help you choose the right product based on your prescription, it is important that you do your own research on the different products available.

Each medical cannabis product has its pros and cons, with the most common products being THC vapes, marijuana topicals and marijuana edibles. It is important to ask your physician about anything you’re unsure of with regard to your prescription and communicate any uneasiness you may feel to ensure you see the most benefit from your treatment.

Some companies, such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), have taken the added step to develop cannabis-based treatments that they hope will be approved by regulators, such as the FDA, for use by patients even in regions where medical marijuana isn’t legal yet.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Positioned to Benefit from Revised Colombian Regulations, Is Covered by Argus Research Report

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, has announced that new Colombian regulations allow the company to increase revenue both long and short term. The regulations also enhance the company’s global supply chain of premium brands and products, and expand economics both domestically and abroad. The changes were made when the president of Colombia accepted and signed into effect revisions to existing Colombian cannabis laws. Revisions now allow for the sale and export of raw cannabis materials, including dried flower, to international markets. In addition, Colombian cultivators are now positioned to be leading suppliers to the global cannabis market. The revised regulations also permit the manufacturing, sale and export of ingestible cannabinoid products in Colombia, providing near-term revenue potential for Flora’s Kasa Wholefoods division. “This legislative update immediately accelerates Flora’s ability to generate revenue through the sale of our cannabis flower to international markets, as noted by our first international supply agreement. Having the ability to export our high-margin, high-quality cannabis flower – in addition to selling cannabinoid ingestible products – will meaningfully impact our growth and revenue generation,” Flora Growth Chief Revenue Officer Jason Warnock stated in the news release. “We are very excited to leverage our existing product portfolio and distribution channels to quickly deliver these new products to Colombians and our international partners.”

In addition, Argus Research, an independent investment research firm, released an Equity Research Report coverage on Flora Growth. The report noted that FLGC leverages cost-effective cannabis cultivation in Colombia and supplies cannabis as well as its derivatives for an expanding range of products, including cosmetics, pharmaceuticals, food and beverages, and hemp-based textiles. The report noted that FLGC’s Colombian cultivation operation benefits from favorable weather and produces harvest year-round, with costs lower than other Colombian producers. “In our view, Flora Growth is well positioned to participate in a global cannabis market that BDS Analytics projects will reach $56 billion by 2026, up from $21 billion in 2020,” the report states.

To view the full research report, visit https://cnw.fm/QDrbM

To view the full press releases, visit https://cnw.fm/el5Cj and https://cnw.fm/UCzYf

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGr o wth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Pioneering Future-Looking Ideals and Products

Grapefruit USA (OTCQB: GPFT), a fully licensed premier manufacturer and distributor in the legal cannabis marketplace, is committed to being an industry leader by using science and technology to create truly disruptive products for both the recreational and medicinal cannabis marketplace. GPFT recently announced that it is accepting cryptocurrency as payment for its full-spectrum THC Hourglass time-release technology-powered products through its newly launched e-commerce platform, joining other leaders in the cannabis space in paving the way. A recent article reads, “Grapefruit is building a well-earned reputation for pioneering future-looking ideals and products. The company’s flagship product features cutting-edge science and technology that solves the age-old problem of THC and other cannabinoids not being easily absorbed through the skin. Grapefruit’s Hourglass topical cream uses patented micro-sized particles to slowly deliver THC and a wide range of cannabinoids through skin topical administration. No other topical cream product in the market provides users with the holistic benefits of the range of cannabinoids found in Hourglass, including THC+CBD, CBN, CBG, Delta8, THCV and CBE.”

To view the full article, visit https://cnw.fm/Z7C8D

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Following Passion in Electronic Music Industry

Golden Triangle Ventures (OTC: GTVH) and its subsidiary Lavish Entertainment completed the acquisition of Syndicate Bass Records LLC, a label collection curated by individuals who strongly believe in the impact of the bass music scene around the world. The move enables GTVH to debut its own experimental bass music record label. Commenting on the acquisition, Golden Triangle Ventures vice president Malachi Farrow, who also serves as Syndicate Bass Records CEO, said, “We are excited to follow our passion in the electronic music industry. . . . Everyone on our team has been in the bass music scene searching for the most unique sounds and talents available in the market, and it’s an honor to be a part of something we’ve been so deeply involved in for years.” In addition to the Syndicate Bass acquisition, Lavish Entertainment announced that it had formed a partnership with Dan Dailey, aka CVPTVGON, a renowned bass music producer, to assist with an array of exciting upcoming projects. A recent article reads, “This partnership will help drive the forward trajectory of the entire business and provide a significant value to the company label releases, bookings and other projects that will be disclosed in the months ahead.”

To view the full article, visit https://cnw.fm/14lUf

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Stands Distinct in Water Provision

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), the country’s largest independent alkaline water company, recently announced plans to join the Russell Microcap(R) Index. “Russell Indexes are part of FTSE Russell, a leading index provider known for providing critical, innovative benchmarking, analytics and data solutions for investors around the world,” reads a recent article. “Along with membership in the Russell Microcap Index comes automatic inclusion in other appropriate growth and value style indexes. Membership in those indexes is determined by FTSE Russell based on objective, market-capitalization rankings, and style attributes. The Alkaline Water Company’s inclusion in the indexes is clear evidence of its success in building a strong, successful beverage portfolio that includes Alkaline88(R), A88 Infused(R) and A88CBD(TM). The company is dedicated to purity, quality, value and taste, and is focused on making a difference in the water people drink.”

To view the full article, visit https://cnw.fm/eNZ7z

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with ecofriendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts WTER’s trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes the company’s lab-tested, hemp-extract salves, balms, lotions, essential oils, bath salts, powder packs, oil tinctures, capsules and gummies. To purchase Alkaline88 and A88 Flavor Infused products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — A BHO and CO2 Cannabis Extraction Comparison

Despite being prohibited, cannabis has been immensely popular over the past couple of decades. Cannabis proved to be a lucrative space once territories began legalizing the substance for medical and recreational use, but things blew up once cannabis concentrates hit the market. Thanks to constantly improving technology, processors are now able to pull cannabinoids from the plant, creating high-potency cannabis products that have enjoyed major sales.

Extracting cannabinoids and terpenes from hemp and cannabis is an insanely complex process, with the most common extraction methods thus far being butane hash oil (“BHO”) and carbon dioxide (“CO2”) extraction.

BHO, which is a solvent-based extraction method, uses a light hydrocarbon solvent called butane to strip cannabis plants of their resin. Although this method dates back to the 1970s, it can be dangerous because butane is highly flammable, thus requiring specialized training as well as closed-loop equipment for extraction. Closed loop refers to a system that pulls compounds from the cannabis in a completely airtight environment.

If done correctly and under the proper conditions, BHO can produce extracts with up to 90% THC, resulting in high-potency products that can be used for edibles, vaping and topical treatments, among others. Carbon dioxide extraction, on the other hand, uses pressurized CO2 to pull compounds from cannabis. Most of the cannabis oil used in vape cartridges is extracted via CO2 extraction. Like BHO extraction, carbon dioxide extraction requires the use of specialized equipment, and amateurs with no training are advised to avoid both of these extraction methods.

Due to the complexity and newness of BHO and CO2 extraction in the cannabis industry, a lot of people don’t know much about them. For instance, there seems to be a misconception about butane hash leaving residual solvents and producing impure extracts with an unpleasant taste, which is false. In fact, carbon dioxide extraction often uses a second solvent to winterize or crystallize the extract, which has to be removed later on. As a result, extracts made via this process also run the risk of contamination. Additionally, carbon dioxide extraction can be especially dangerous as CO2 extraction systems operate under extremely high pressures, ranging from 1,500-8,700 PSI.

As long as both methods are implemented by trained individuals using the right equipment and in controlled environments, the resultant extract will be quite safe to consume. However, note that there will be slight product differences. Since CO2 extraction calls for a lot of post processing, it may have a reduced natural flavor and a different consistency. It will also take longer compared to BHO processing, which has less post-processing steps. Due to the complexity and equipment required for these extraction methods, consumers should leave extraction to the experts and stick to easier alternatives such as cannabutter and cannaoil.

Consumers are encouraged to stick to high-quality cannabis extracts made by some of the leading companies in the industry, such as Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF), to avoid putting themselves and others at risk while trying to DYI their own extracts.

NOTE TO INVESTORS: The latest news and updates relating to Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) are available in the company’s newsroom at https://cnw.fm/CHALF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Clinical Studies Shed Light on Various Wellness Benefits of Phytocannabinoids

The CBD sector is among the fastest-growing subcategories of consumer natural health products and for good reason. A recent report estimates that last year, the international consumer health CBD market was worth more than $9 billion, with an expected compound annual growth rate of nearly 25% in the period between 2020–2027.

Studies linking health and wellness to CBD have also driven the manufacture of products derived from CBD in industries such as food and beverages, nutraceuticals, personal care and cosmetics and pharmaceuticals, for health and wellness purposes.

Verdant Oasis VP Carl Germano states that new research which sheds light on the role of hemp phytocannabinoids such as CBD in supporting the endocannabinoid system will influence medicine and nutrition significantly.

Phytocannabinoids are cannabinoids that occur naturally in the marijuana plant. Thus far, researchers have identified more than 120 terpenes and 100 cannabinoids.

Below are some of the uses of CBD and other phytocannabinoids in wellness applications.

Skin conditions

Research has found that CB1 and CB2, which are cannabinoid receptors, are found in hair follicles, eccrine sweat glands, melanocytes, dermal cells, cutaneous nerve fibers and epidermal keratinocytes. A study that administered CBD to cultured human sebocytes found that CBD could be used as a therapeutic agent for treating acne vulgaris because of its combined anti-inflammatory, anti-proliferative and lipostatic effects.

Dr. Jacknin’s Skincare CEO Jeanette Jacknin asserted that research had shown that topical CBD as well as other cannabinoids could help in wounds, eczema and acne and suggested that cannabinoids may also help with itching.

Anxiety

A recent review that centered on anxiety disorders and CBD found that CBD held significant potential as a treatment for multiple anxiety disorders. CBD also demonstrated effectiveness in decreasing anxiety in social anxiety disorder.

Immune/respiratory health

In a modeling study that simulated symptoms of acute respiratory distress syndrome, treatment using CBD reversed symptoms by increasing the quantity of a peptide known as apelin, which plays a crucial role in the peripheral and central regulation of immunity.

Another study found that cannabidiol could alleviate the uncontrolled cytokine production responsible for damaging lung tissue, in addition to launching numerous anti-inflammatory and immunomodulatory effects.

Bone health

There is increasing evidence that suggests that phytocannabinoids have a positive effect on the musculoskeletal system. Research has found that CB1 and CB2 receptors, which can be found in bones, help to regulate bone maintenance. In animal studies, researchers have discovered that CBD can protect against bone loss and improve the healing of bone tissue.

With more interest and funds being directed to cannabinoid research to discover the therapeutic benefits they deliver, the CBD market is expected to grow significantly in the future.

As more becomes known about the benefits of phytocannabinoids, companies that make cannabinoid supplements and supplements, such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), are likely to benefit.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Q4, FY 2020 Financial Reports

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has reported fourth quarter and full year 2020 financial results and company highlights. The report noted that Q4 2020 adjusted sales totaled C$28.6 million, an increase of 290% over the third quarter, with fourth quarter 2020 revenue reaching C$15.7 million, an increase of 158% over the third quarter. Finally, full year 2020 adjusted sales topped more than $37.8 million with revenue coming in at $23.3 million. In addition, the announcement noted that RWB closed two significant acquisitions, completed its go-public transaction and established its first THC operations and brands, as well as raised more than $100 million to support expansion and operation efforts. In addition, Red White & Bloom announced that it has scheduled a conference call and audio webcast to provide an overview of the company’s 2020 and Q1 2021 operating results and 2021 outlook; the webcast will also include a Q&A session. Anyone interested can participate by calling (877) 705-6006 toll-free or (201) 689-8557 for international. “We set out at the beginning of 2020 with a three-year plan for our success,” said Red White & Bloom CEO and chair Brad Rogers in the press release. “Our strategy was to establish a foundation for the overall company and identify the core states to operate in and a plan to scale in those states. We have set the foundation for our core states including Michigan, Illinois, Florida and California. In 2021 we look to expand through an asset light approach in other states, such as Arizona, and complete the integration of our M&A targets while gaining operational synergies from all we have accomplished over the last 18 months. For the balance of 2021 and throughout 2022, the company will focus on the continued growth of our topline revenue and bottom-line results through expansion of our house of brands that continue to gain momentum, fortification of our vertically integrated businesses, and the synergies from our M&A success.”

To view the webcast, visit https://cnw.fm/UUj31

To view the full press release, visit https://cnw.fm/G70HR

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Could Have Origins in China, Study Says

After being outlawed in most regions across the world for decades, cannabis is coming out from under the yoke of prohibition. It has been a slow process and although the sector has shown that it has plenty of potential, cannabis still has a long way to go. However, researchers are finally getting the chance to run more in-depth studies on cannabis, and they are uncovering plenty of interesting information.

For starters, a recent study has found evidence pointing to China, specifically the northwest region of China, as home to the first domesticated cannabis and hemp. The common assumption is that cannabis sativa originated from East Asia, but its illegality over the past century has prevented research into its history and use. The study team, helmed by Swiss and Chinese researchers, took advantage of loosening cannabis restrictions and conducted an in-depth study on the history of cannabis and hemp.

The researchers concluded that the cannabis sativa species likely emerged from China’s northwest region by an estimated 10,000 to 3,000 BC (Neolithic period). According to a news release by the journal that published the study, “Science Advances,” cannabis and hemp were among the very first plants to be domesticated by humans, with humans using hemp to produce textiles, food and oilseed.

To arrive at these conclusions, the team compiled 110 whole genomes covering everything from different feral, wild-growing plants and domesticated varieties to modern hemp hybrids and psychoactive cannabis. They separated their genomic analysis samples into four different groups, including basal cannabis which is usually found in the United States and China. The data suggested that basal cannabis diverged from the ancestors of modern marijuana and hemp nearly 12,000 years ago, giving weight to the theory that by that point in history, the cannabis sativa species had been domesticated already. Furthermore, the study says, it coincides with ancient artifacts such as pottery from Southern China, Japan and Taiwan that has been dated to that period.

Once humans in the Neolithic period had domesticated cannabis, it spread across the Middle East and Europe during the Bronze Age, appearing in India nearly 3,000 years ago after likely being introduced with other crops from China, the study says. Cannabis arrived in Africa during the 13th century and traveled to Latin America in the 16th century before reaching North America at the start of the 20th century.

The closest descendants to the ancient hemp and marijuana are modern Chinese cannabis, altered by years of cultivation, and feral, wild-growing cannabis plants, the study says. However, it is likely that the cannabis sativa’s pure wild ancestors have gone extinct.

It is amazing how much researchers continue to learn about marijuana. Sector players such as Hero Technologies Inc. (OTC: HENC) must be having their own fair share of surprising discoveries about this versatile yet controversial plant.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Senator Files Bill to Protect Licensed Marijuana Extractors from Eviction

Although the past decade has seen America’s state legal cannabis industry experience major growth, federal law has consistently held the sector back. Cannabis is classified as a Schedule I controlled substance, and this classification has been a constant barrier for both businesses in the cannabis space and the clients they serve. Fortunately, an increasing number of lawmakers have noticed the plight of the cannabis sector, which has provided states with millions of dollars in tax revenue, and they have been working to give the space more protections.

After an affordable housing bill failed to advance in Congress last month, Senator Jeff Merkley again introduced a bill that includes a provision preventing landlords from evicting state-licensed people who manufacture cannabis extracts. The bill, whose language is identical to the bill filed last month, has a “just causes for eviction” section containing common reasons for eviction, including defaulting on rent and causing significant property damage. It also lists “manufacture of a cannabis extract” as a legal reason for eviction, adding that tenants who hold a manufacturing license under federal, state or tribal law are exempt.

However, the bill does not provide any protections for tenants who take part in other state-legal cannabis-related activities such as possession. Curiously, the bill contains language that states that manufacturing, delivering or possessing controlled substances is enough grounds for eviction. Since cannabis is technically a controlled substance according to federal law, some landlords could choose to defer to federal law rather than state law and evict tenants who perform any of the aforementioned actions.

The inclusion of language offering protections for individuals who take part in state-legal cannabis activities in an affordable housing bill will definitely make cannabis reform advocates happy, but it may very well be inconsequential. This is because eviction proceedings tend to be handled at the state level; the assumption is that courts would turn to state law when dealing with eviction cases that concern cannabis.

Additionally, the chances of an individual being licensed by the state to perform cannabis manufacturing activities at their premises are close to zero. As such, it is not clear just how impactful the provision for manufacturing licenses would be if the proposed policy becomes law.

The comprehensive housing bill, which contains the cannabis provision, aims to correct the pitfalls of America’s housing policies and funding by addressing systemic disparities and obstacles and ensuring every American, especially the most vulnerable, has an equitable outcome.

The entire cannabis industry, including companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), may regard the rolling back of restrictions on housing as a bonus in the drive to see the cannabis industry federally legalized and given equal treatment as other legal sectors.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.